Raymond James Financial’s Sanara MedTech SMTI Stock Holding History

Raymond James Financial’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52	Closed	-$1.48K	–	6493
2025 Q2	$1.48K	Buy	+52	New	+$1.56K	﹤0.01%	6487

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Raymond James Financial's SMTI Position: Q3 2025 in Review

Raymond James Financial sold out of Sanara MedTech (SMTI) in Q3 2025, closing a stake of 52 shares — an estimated $1.48K sold.

Raymond James Financial first reported a position in SMTI in Q2 2025 and held it in 1 quarter. The position peaked at $1.48K in Q2 2025. 58 funds tracked by Wall St. Rank hold SMTI as of Q3 2025.

Raymond James Financial reported no remaining Sanara MedTech position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 52 Sanara MedTech shares in Q3 2025, an estimated $1.48K.
Raymond James Financial first reported a position in Sanara MedTech in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Sanara MedTech position peaked at $1.48K in Q2 2025.
58 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.